Skip to main content
AnGes, Inc. logo

AnGes, Inc. — Investor Relations & Filings

Ticker · 4563 ISIN · JP3127700007 LEI · 529900HERUBGP6BTMO45 T Manufacturing
Open in API
Filings indexed 71 across all filing types
Latest filing 2023-03-31 Audit Report / Informat…
Country JP Japan
Listing T 4563

About AnGes, Inc.

https://www.anges.co.jp/en/

AnGes, Inc. is a biopharmaceutical company specializing in the research and development of gene-based and nucleotide-based medicines. The company's core focus is its Hepatocyte Growth Factor (HGF) gene therapy product, designed to treat ischemic diseases by regenerating blood vessels. This product was the first gene therapy medicine to receive marketing approval in Japan. AnGes leverages its expertise in plasmid DNA technology across its development pipeline, which also includes an NFkB decoy oligonucleotide and DNA vaccines. The company is dedicated to developing novel treatments for various conditions, including rare diseases.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It confirms the accuracy of the contents of the Annual Securities Report (Yuuka Shouken Houkokusho) for the fiscal year ending December 31, 2022. Since this is a regulatory filing required to accompany the annual report and does not fit into the specific categories of financial reports or announcements, it falls under the general regulatory filings category. FY 2022
2023-03-31 Japanese
有価証券報告書－第24期(2022/01/01－2022/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes detailed financial statements, business indicators, and management information for the fiscal year ending December 31, 2022. It is a comprehensive regulatory filing, not an announcement or a summary. FY 2022
2023-03-31 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, specifically confirming the accuracy of the contents of a Quarterly Report (四半期報告書) for the third quarter of the 24th fiscal period. Since this is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the general regulatory filing category.
2022-11-16 Japanese
訂正四半期報告書－第24期第3四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and business updates for the third quarter of the 24th fiscal period (July 1, 2022, to September 30, 2022). It is a comprehensive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-16 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of the Quarterly Report (Shihanki Hokokusho) for the third quarter of the 24th fiscal period. Since this is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the general regulatory filing category.
2022-11-11 Japanese
四半期報告書－第24期第3四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed by AnGes, Inc. with the Kanto Local Finance Bureau in Japan. It covers the third quarter of the 24th fiscal period (July 1, 2022, to September 30, 2022). It contains detailed financial statements, management analysis (MDA), and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.